Hepatitis B Viral Protein HBx and the Molecular Mechanisms Modulating the Hallmarks of Hepatocellular Carcinoma: A Comprehensive Review
- PMID: 35203390
- PMCID: PMC8870387
- DOI: 10.3390/cells11040741
Hepatitis B Viral Protein HBx and the Molecular Mechanisms Modulating the Hallmarks of Hepatocellular Carcinoma: A Comprehensive Review
Abstract
With 296 million cases estimated worldwide, chronic hepatitis B virus (HBV) infection is the most common risk factor for hepatocellular carcinoma (HCC). HBV-encoded oncogene X protein (HBx), a key multifunctional regulatory protein, drives viral replication and interferes with several cellular signalling pathways that drive virus-associated hepatocarcinogenesis. This review article provides a comprehensive overview of the role of HBx in modulating the various hallmarks of HCC by supporting tumour initiation, progression, invasion and metastasis. Understanding HBx-mediated dimensions of complexity in driving liver malignancies could provide the key to unlocking novel and repurposed combinatorial therapies to combat HCC.
Keywords: HBx protein; cancer hallmarks; hepatitis B virus; hepatocellular carcinoma; therapeutics.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

References
-
- World Health Organization Global Progress Report on HIV, Viral Hepatitis and Sexually Transmitted Infections. 2021. [(accessed on 29 December 2021)]. Available online: https://www.who.int/publications/i/item/9789240027077.
-
- Kgatle M. Advances in Treatment of Hepatitis C and B. IntechOpen; London, UK: 2017. Recent advancement in hepatitis b virus, epigenetics alterations and related complications.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical